UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Status of the ECR ion source at the Uppsala cyclotron

Review of Scientific Instruments, 1992-04, Vol.63 (4), p.2878-2880

1992

Volltextzugriff (PDF)

Time of flight measurements of the energy spectrum of neutrons emitted from a spallation source and moderated in water

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 1987-11, Vol.261 (3), p.587-590

1987

Volltextzugriff (PDF)

What could be learned from the utilization of Design for Environment within manufacturing companies?

2005 4th International Symposium on Environmentally Conscious Design and Inverse Manufacturing, 2005, p.232-237

2005

Volltextzugriff (PDF)

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation

JACC. Heart failure, 2023-01, Vol.11 (1), p.1-14

2023

Volltextzugriff (PDF)

The production by 72 MeV protons of keV neutrons for 10B neutron capture therapy

Strahlentherapie und Onkologie, 1989-04, Vol.165 (4), p.340-342

1989

Volltextzugriff (PDF)

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.344-351

2018

Volltextzugriff (PDF)

Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study

Bipolar disorders, 2015-02, Vol.17 (1), p.76-85

2015

Volltextzugriff (PDF)

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

The lancet. Diabetes & endocrinology, 2017-09, Vol.5 (9), p.709-717

2017

Volltextzugriff (PDF)

Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2018-01, Vol.177 (1), p.10-20

2018

Volltextzugriff (PDF)

Reduced cell surface levels of GPI‐linked markers in a new case with PIGG loss of function

Human mutation, 2017-10, Vol.38 (10), p.1394-1401

2017

Volltextzugriff (PDF)

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure

Heart (British Cardiac Society), 2023, Vol.109 (7), p.548

2023

Volltextzugriff (PDF)

Mutations in HECW2 are associated with intellectual disability and epilepsy

Journal of medical genetics, 2016-10, Vol.53 (10), p.697-704

2016

Volltextzugriff (PDF)

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.968-974

2019

Volltextzugriff (PDF)

Apparent Half-Lives of Hepta- to Decabrominated Diphenyl Ethers in Human Serum as Determined in Occupationally Exposed Workers

Environmental health perspectives, 2006-02, Vol.114 (2), p.176-181

2006

Volltextzugriff (PDF)

Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF)

JACC. Heart failure, 2023-01, Vol.11 (1), p.1-14

2023

Volltextzugriff (PDF)

Cancer risk in patients with diverticular disease: A nationwide cohort study

JNCI : Journal of the National Cancer Institute, 2023-01, Vol.115 (1), p.62-70

2023

Volltextzugriff (PDF)

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

The lancet. Diabetes & endocrinology, 2020-01, Vol.8 (1), p.27-35

2020

Volltextzugriff (PDF)

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Cardiovascular diabetology, 2019-10, Vol.18 (1), p.138-12, Article 138

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada

Journal of medical economics, 2015-03, Vol.18 (3), p.173-188

2015

Volltextzugriff (PDF)

Gastrointestinal cancer precursor risk and mortality in pancreatic intraductal papillary mucinous neoplasms: a nationwide cohort study

Scandinavian journal of gastroenterology, 2024, Vol.59 (5), p.1-607

2024

Volltextzugriff (PDF)

Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL

Diabetes care, 2019-02, Vol.42 (2), p.318-326

2019

Volltextzugriff (PDF)

Cavity-enhanced storage-preparing for high-efficiency quantum memories

New journal of physics, 2013-03, Vol.15 (3), p.35025-13

2013

Volltextzugriff (PDF)

Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF

JACC. Heart failure, 2023-10, Vol.11 (10), p.1320-1332

2023

Volltextzugriff (PDF)

Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups

Blood, 2011-01, Vol.117 (2), p.678-687

2011

Volltextzugriff (PDF)

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

Leukemia & lymphoma, 2019-06, Vol.60 (7), p.1668-1676

2019

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Status of the ECR ion source at the Uppsala cyclotron

Time of flight measurements of the energy spectrum of neutrons emitted from a spallation source and moderated in water

What could be learned from the utilization of Design for Environment within manufacturing companies?

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation

The production by 72 MeV protons of keV neutrons for 10B neutron capture therapy

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability

Reduced cell surface levels of GPI‐linked markers in a new case with PIGG loss of function

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure

Mutations in HECW2 are associated with intellectual disability and epilepsy

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Apparent Half-Lives of Hepta- to Decabrominated Diphenyl Ethers in Human Serum as Determined in Occupationally Exposed Workers

Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF)

Cancer risk in patients with diverticular disease: A nationwide cohort study

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada

Gastrointestinal cancer precursor risk and mortality in pancreatic intraductal papillary mucinous neoplasms: a nationwide cohort study

Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL

Cavity-enhanced storage-preparing for high-efficiency quantum memories

Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF

Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

Suchergebnisse filtern